Millbrae, CA, United States of America

David Albagli


Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 230(Granted Patents)


Location History:

  • Palo Alto, CA (US) (1997 - 2003)
  • Menlo Park, CA (US) (2001 - 2004)
  • Millbrae, CA (US) (2002 - 2004)

Company Filing History:


Years Active: 1997-2004

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations by David Albagli

Introduction

David Albagli is a prominent inventor based in Millbrae, California. He has made significant contributions to the field of nucleic acid detection, holding a total of 13 patents. His work focuses on developing methods and compositions that enhance the detection of nucleic acid sequences, which are crucial in various biological and medical applications.

Latest Patents

One of Albagli's latest patents involves the use of nucleic acid sequence detection employing probes that comprise non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents. This innovative method allows for the detection of specific nucleic acid sequences by combining probes with a sample that may contain a complementary target sequence. The process includes hybridization between the probe and the target, followed by the activation of a crosslinking agent to form covalent bonds, enabling the detection of the target sequence.

Another notable patent focuses on improved methods for in situ hybridization assays of cellular and subcellular systems. This invention enhances techniques such as Northern blotting, Southern blotting, and dot blots by employing crosslinker-containing hybridization probes. These probes can form covalent bonds with the target nucleic acid upon activation, allowing for more accurate detection while minimizing background signals.

Career Highlights

David Albagli is currently associated with Naxcor, Inc., where he continues to innovate in the field of nucleic acid detection. His extensive experience and expertise have positioned him as a key figure in advancing methodologies that are essential for clinical and diagnostic laboratories.

Collaborations

Albagli has collaborated with notable colleagues, including Michael L. Wood and Peter C. Cheng. Their combined efforts contribute to the development of cutting-edge technologies in the realm of molecular biology.

Conclusion

David Albagli's contributions to the field of nucleic acid detection through his innovative patents and collaborations highlight his significant role as an inventor. His work continues to impact the scientific community and improve diagnostic techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…